| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| U.S. and Canada | | | | | 406.4 | | 478.7 | 546.9 |
| Halloween | 107.6 | 88.8 | 119.6 | 101.6 | 99.5 | | 97.2 | 141.6 |
| International | | | | | 107.2 | | 169.8 | 121.6 |
| Other | 513.5 | 427.1 | 479.0 | 466.2 | | | | |
| Total revenues | 621.1 | 515.9 | 598.6 | 567.8 | 613.1 | 706.6 | 745.7 | 810.1 |
| Revenue growth [+] | 20.4% | -13.8% | 5.4% | -7.4% | -13.2% | -5.2% | -7.9% | 28.0% |
| U.S. and Canada | | | | | | | -12.5% | |
| Halloween | 21.2% | -25.8% | 17.7% | 2.2% | | | -31.4% | |
| International | | | | | | | 39.7% | |
| Cost of goods sold | 438.2 | 366.1 | 439.3 | 412.1 | 457.4 | 483.6 | 517.2 | 574.3 |
| Gross profit | 183.0 | 149.8 | 159.3 | 155.7 | 155.7 | 223.0 | 228.6 | 235.8 |
| Gross margin | 29.5% | 29.0% | 26.6% | 27.4% | 25.4% | 31.6% | 30.6% | 29.1% |
| Selling, general and administrative [+] | 141.8 | 132.0 | 154.7 | 185.1 | 205.2 | 205.9 | 198.0 | 204.5 |
| Sales and marketing | 43.1 | 41.6 | 55.1 | | | | | |
| Other selling, general and administrative | 98.7 | 90.4 | 99.6 | | | | | |
| Equity in earnings | | 0.0 | | 0.2 | 0.1 | 0.9 | 2.8 | 0.3 |
| Other operating expenses | | 0.4 | | | | | -5.6 | -5.9 |
| EBITDA [+] | 49.0 | 25.5 | 15.8 | -12.1 | -28.4 | 40.9 | 57.8 | 56.5 |
| EBITDA growth | 92.4% | 61.6% | -230.1% | -57.4% | -169.5% | -29.2% | 2.2% | -431.0% |
| EBITDA margin | 7.9% | 4.9% | 2.6% | -2.1% | -4.6% | 5.8% | 7.7% | 7.0% |
| Depreciation | 9.3 | 9.7 | 12.9 | 12.2 | 13.0 | 14.1 | 10.9 | 10.5 |
| EBITA | 39.8 | 15.7 | 2.8 | -24.3 | -41.4 | 26.8 | 46.9 | 46.1 |
| EBITA margin | 6.4% | 3.1% | 0.5% | -4.3% | -6.8% | 3.8% | 6.3% | 5.7% |
| Amortization of intangibles | 1.0 | 1.2 | 4.7 | 4.9 | 8.0 | 8.8 | 8.0 | 8.5 |
| EBIT [+] | 38.8 | 14.5 | -1.9 | -29.2 | -49.4 | 18.0 | 38.9 | 37.6 |
| EBIT growth | 166.6% | -879.7% | -93.6% | -40.9% | -374.7% | -53.8% | 3.6% | -190.1% |
| EBIT margin | 6.2% | 2.8% | -0.3% | -5.1% | -8.1% | 2.5% | 5.2% | 4.6% |
| Non-recurring items [+] | | 1.6 | 15.9 | 2.7 | 14.6 | | 5.6 | 5.9 |
| Asset impairment | | | 9.4 | | 13.5 | | | |
| Loss on contingent liability | | | | | | | 5.6 | 5.9 |
| Interest expense, net [+] | 14.1 | 21.5 | 15.9 | 10.2 | 9.8 | 12.9 | 12.3 | 12.3 |
| Interest expense | 14.1 | 21.6 | 15.9 | 10.2 | 9.8 | 13.0 | 12.4 | 12.5 |
| Interest income | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 |
| Other income (expense), net [+] | -30.3 | -4.8 | -19.8 | 2.6 | -7.6 | 0.3 | 5.6 | 5.9 |
| Impairment of investments | | | | | 7.0 | | | |
| Gain (loss) on debt retirement | -7.4 | | -13.2 | -0.5 | -0.6 | 0.1 | | |
| Change in value of contingent liability | | | | | | | | 5.9 |
| Other | 0.4 | 0.3 | -1.2 | 0.2 | 0.3 | 0.3 | | |
| Pre-tax income | -5.7 | -13.4 | -53.5 | -39.5 | -81.4 | 5.4 | 26.6 | 25.2 |
| Income taxes | 0.2 | 0.7 | 1.9 | 3.0 | 1.6 | 4.1 | 3.4 | 3.7 |
| Tax rate | | | | | | 76.8% | 12.9% | 14.7% |
| Minority interest | 0.1 | 0.1 | 0.2 | -0.1 | 0.1 | 0.0 | -0.1 | |
| Net income | -7.3 | -15.5 | -56.0 | -42.4 | -83.1 | 1.2 | 23.3 | 21.5 |
| Net margin | -1.2% | -3.0% | -9.4% | -7.5% | -13.6% | 0.2% | 3.1% | 2.7% |
| |
| Basic EPS [+] | ($0.98) | ($4.27) | ($21.57) | ($18.34) | ($3.89) | $0.08 | $1.20 | $1.03 |
| Growth | -77.1% | -80.2% | 17.6% | 371.1% | -5281.1% | -93.7% | 16.5% | -142.3% |
| Diluted EPS [+] | ($0.98) | ($4.27) | ($21.57) | ($18.34) | ($3.89) | $0.07 | $0.54 | $0.52 |
| Growth | -77.1% | -80.2% | 17.6% | 371.1% | -5319.7% | -86.1% | 3.6% | -121.3% |
| |
| Growth | | | | | | | | -100.0% |
| |
| Shares outstanding (basic) [+] | 7.5 | 3.6 | 2.6 | 2.3 | 21.3 | 16.5 | 19.4 | 20.9 |
| Growth | 106.3% | 39.9% | 12.5% | -89.2% | 29.0% | -14.9% | -7.2% | -5.6% |
| Shares outstanding (diluted) [+] | 7.5 | 3.6 | 2.6 | 2.3 | 21.3 | 16.7 | 43.3 | 41.5 |
| Growth | 106.3% | 39.9% | 12.5% | -89.2% | 28.1% | -61.5% | 4.3% | 87.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |